Shareholder information
Shareholder information
For information on the demerger and Haleon.
Shareholders can view the Prospectus in relation to the admission of the Haleon plc ordinary shares along with associated documents via the links below.
Articles of Association of Haleon plc
Deloitte’s written consent letter
Deloitte’s report on the Unaudited Pro Forma Financial Information of the Group
Deloitte’s report on the Pfizer Historical Financial Information
A comprehensive list of shareholder FAQs relating to the Demerger can be found on the Shareview website. If you have any additional questions, feel free to contact our Registrars, Equiniti Limited via one of the methods below:
Details about how to contact Equiniti are available here.
Equiniti Limited shareholder helpline: +44 (0) 371 384 2227
Calls to this number are charged at 8p per minute from a BT landline. Other telephony providers' costs may vary.
or by writing to:
Equiniti Limited
Aspect House
Spencer Road
Lancing
West Sussex
BN99 6DA
Related
